has been cited by the following article(s):
|
[1]
|
Mixed‐Tetravalent Cs2RumPt1−mX6 (X = Cl−, Br−)‐Based Vacancy‐Ordered Halide Double Perovskites for Enhanced Solar Water Oxidation
|
|
Solar …,
2024 |
|
|
|
|
[2]
|
Nikkeli-ja kupariryhmien bis (difenyylifosfiini) metaanikompleksit
|
|
2023 |
|
|
|
|
[3]
|
3′-Aminothiocyclohexanespiro-5′-hydantoin and Its Pt (II) Complex-Synthesis, Cytotoxicity and Xanthine Oxidase Inhibitory Activity. Inorganics (Basel). 2022; …
|
|
2022 |
|
|
|
|
[4]
|
Platinum (IV) Complexes of the 1, 3, 5-Triamino Analogue of the Biomolecule Cis-Inositol Designed as Innovative Antineoplastic Drug Candidates
|
|
Pharmaceutics,
2022 |
|
|
|
|
[5]
|
3′-Aminothiocyclohexanespiro-5′-hydantoin and Its Pt (II) Complex—Synthesis, Cytotoxicity and Xanthine Oxidase Inhibitory Activity
|
|
Inorganics,
2022 |
|
|
|
|
[6]
|
3-Aminothiocyclohexanespiro-5-hydantoin and Its Pt (II) Complex—Synthesis, Cytotoxicity and Xanthine Oxidase Inhibitory Activity. Inorganics 2022, 10, 175
|
|
2022 |
|
|
|
|
[7]
|
Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt (II)-methionine coordination chemistry
|
|
Nucleic Acids Research,
2017 |
|
|
|
|
[1]
|
Platinum(IV) Complexes of the 1,3,5-Triamino Analogue of the Biomolecule Cis-Inositol Designed as Innovative Antineoplastic Drug Candidates
Pharmaceutics,
2022
DOI:10.3390/pharmaceutics14102057
|
|
|
|
|
[2]
|
3′-Aminothiocyclohexanespiro-5′-hydantoin and Its Pt(II) Complex—Synthesis, Cytotoxicity and Xanthine Oxidase Inhibitory Activity
Inorganics,
2022
DOI:10.3390/inorganics10100175
|
|
|
|